AAAAAA

   
Results: 1-11 |
Results: 11
Methylation and silencing of the retinoic acid receptor-beta 2 gene in breast cancer
Authors: Widschwendter, M Berger, J Hermann, M Muller, HM Amberger, A Zeschnigk, M Widschwendter, A Abendstein, B Zeimet, AG Daxenbichler, G Marth, C
Citation: M. Widschwendter et al., Methylation and silencing of the retinoic acid receptor-beta 2 gene in breast cancer, J NAT CANC, 92(10), 2000, pp. 826-832
Expression of retinoic acid receptors in non-neoplastic epithelial disorders of the vulva and normal vulvar skin
Authors: Berger, J Telser, A Widschwendter, M Muller-Holzner, E Daxenbichler, G Marth, C Zeimet, AG
Citation: J. Berger et al., Expression of retinoic acid receptors in non-neoplastic epithelial disorders of the vulva and normal vulvar skin, INT J GYN P, 19(2), 2000, pp. 95-102
Peritoneal mesothelial cells as a significant source of ascitic immunostimulatory protein 90K
Authors: Zeimet, AG Stadlmann, S Natoli, C Widschwendter, M Hermann, M Abendstein, B Daxenbichler, G Offner, FA Iacobelli, S Marth, C
Citation: Ag. Zeimet et al., Peritoneal mesothelial cells as a significant source of ascitic immunostimulatory protein 90K, ANTICANC R, 20(6B), 2000, pp. 4507-4511
Predictive value of uPA, PAI-1, HER-2 and VEGF in the serum of ovarian cancer patients
Authors: Abendstein, B Daxenbichler, G Windbichler, G Zeimet, AG Geurts, A Sweep, F Marth, C
Citation: B. Abendstein et al., Predictive value of uPA, PAI-1, HER-2 and VEGF in the serum of ovarian cancer patients, ANTICANC R, 20(1B), 2000, pp. 569-572
Clinical significance of serum and ascitic p53 autoantibodies in epithelial ovarian carcinoma
Authors: Abendstein, B Marth, C Muller-Holzner, E Widschwendter, M Daxenbichler, G Zeimet, AG
Citation: B. Abendstein et al., Clinical significance of serum and ascitic p53 autoantibodies in epithelial ovarian carcinoma, CANCER, 88(6), 2000, pp. 1432-1437
New insights into p53 regulation and gene therapy for cancer
Authors: Zeimet, AG Riha, K Berger, J Widschwendter, M Hermann, M Daxenbichler, G Marth, C
Citation: Ag. Zeimet et al., New insights into p53 regulation and gene therapy for cancer, BIOCH PHARM, 60(8), 2000, pp. 1153-1163
Interleukin-12 heterodimer in the ascitic fluid of patients with ovarian cancer
Authors: Zeimet, AG Widschwendter, M Hermann, M Muller-Holzner, E Daxenbichler, G Marth, C
Citation: Ag. Zeimet et al., Interleukin-12 heterodimer in the ascitic fluid of patients with ovarian cancer, INT J GYN C, 9(1), 1999, pp. 86-86
Quantitation of gene expression by means of HPLC analysis of RT-PCR products
Authors: Bachmair, F Huber, C Daxenbichler, G
Citation: F. Bachmair et al., Quantitation of gene expression by means of HPLC analysis of RT-PCR products, CLIN CHIM A, 279(1-2), 1999, pp. 25-34
Retinoic acid modulates prolactin receptor expression and prolactin-induced STAT-5 activation in breast cancer cells in vitro
Authors: Widschwendter, M Widschwendter, A Welte, T Daxenbichler, G Zeimet, AG Bergant, A Berger, J Peyrat, JP Michel, S Doppler, W Marth, C
Citation: M. Widschwendter et al., Retinoic acid modulates prolactin receptor expression and prolactin-induced STAT-5 activation in breast cancer cells in vitro, BR J CANC, 79(2), 1999, pp. 204-210
Activated immune system in associated with poor prognosis in ovarian cancer
Authors: Marth, C Windbichler, G Zeimet, AG Daxenbichler, G Graf, A Stummvoll, W Fuchs, D
Citation: C. Marth et al., Activated immune system in associated with poor prognosis in ovarian cancer, 7TH BIENNIAL MEETING OF THE INTERNATIONAL GYNECOLOGIC CANCER SOCIETY, 1999, pp. 247-251
CD44 splice variant expression in normal and malignant uterine cervical epithelium
Authors: Uhl-Steidl, M Huy, VQ Muller-Holzner, E Ruth, N Zeimet, AG Stauder, R Daxenbichler, G Marth, C
Citation: M. Uhl-steidl et al., CD44 splice variant expression in normal and malignant uterine cervical epithelium, INT J GYN C, 8(6), 1998, pp. 460-466
Risultati: 1-11 |